IDF Diabetes Atlas 2021. 10th ed. Brussels, Belgium: International Diabetes Federation; 2021.

World Health Organization. Global report on diabetes. Geneva: World Health Organization; 2016.

Varshney A, Rawat R, editors. A concise textbook of diabetes. 1st ed. Amritsar (India): Dentomed Publishing House; 2021.

Rezaeiamiri ER, Bahramsoltani R, Rahimi BR. Plant-derived natural agents as dietary supplements for the regulation of glycosylated hemoglobin: a review of clinical trials, Clin Nutr 2020;39:331–42. https://doi.org/10.1016/j. clnu.2019.02.006.

Kahaly GJ Hansen MP. Type 1 diabetes-associated autoimmunity. Autoimmun Rev 2016;15:644-8. doi: 10.1016/j.autrev.2016.02.017.

Burrack AL, Martinov T, Fife BT. T cell-mediated beta cell destruction: autoimmunity and alloimmunity in the context of type 1 diabetes. Front Endocrinol (Lausanne) 2017;8:343. doi: 10.3389/fendo.2017.00343.

Banday MZ, Sameer A. S., Nissar S. Pathophysiology of diabetes: an overview. Avicenna J Med 2020;10:174-88. doi: 10.4103/ajm.ajm_53_20.

Khin PP, Lee JH, Jun HS. Pancreatic beta-cell dysfunction in type 2 diabetes. Eur J Inflamm 2023;21:1-13. doi: 10.1177/1721727X231154152.

Galicia-Garcia U, Benito-Vicente A, Jebari S, et al. Pathophysiology of type 2 diabetes mellitus. Int J Mol Sci 2020;21:6275. doi: 10.3390/ijms21176275.

García-Aguilar A, Guillén C. Targeting pancreatic beta cell death in type 2 diabetes by polyphenols. Front Endocrinol 2022;13:1052317. doi: 10.3389/fendo.2022.1052317.

Zheng Y, Ley SH, Hu FB. Global aetiology and epidemiology of type 2 diabetes mellitus and its complications. Nat Rev Endocrinol 2018; 14:88–98. doi: 10.1038/nrendo.2017.151.

Yamamoto WR, Bone RN, Sohn P, et. al. Endoplasmic reticulum stress alters ryanodine receptor function in the murine pancreatic beta cell. J Biol Chem 2019;294:168–81. doi: 10.1074/jbc.RA118.005683.

Halban PA, Polonsky KS, Bowden DW, et. al. Beta-cell failure in type 2 diabetes: postulated mechanisms and prospects for prevention and treatment. J Clin Endocrinol Metab 2014;99: 1983-92. doi: 10.1210/jc.2014-1425.

Czech MP. Insulin action and resistance in obesity and type 2 diabetes. Nat Med 2017; 23:804–14. doi: 10.1038/nm.4350.

Pearson T, Wattis JA, King JR, MacDonald IA, Mazzatti DJ. The effects of insulin resistance on individual tissues: an application of a mathematical model of metabolism in humans. Bull Math Biol 2016; 78:1189–217. doi: 10.1007/s11538-016-0181-1.

Borén, J. Öörni K, Catapano AL. The link between diabetes and cardiovascular disease. Atherosclerosis 2024;394:117607. doi: 10.1016/j.atherosclerosis.2024.117607.

Laakso M, Kuusisto J. Insulin resistance and hyperglycaemia in cardiovascular disease development. Nat Rev Endocrinol 2014;10:293–302. doi: 10.1038/nrendo.2014.29.

Pansuria M, Xi H, Li L, Yang XF, Wang H. Insulin resistance, metabolic stress, and atherosclerosis. Front Biosci (Schol Ed) 2012;4: 916-31. doi: 10.2741/s308.

Ormazabal V, Nair S, Elfeky O, Aguayo C, Salomon C, Zuñiga FA.. Association between insulin resistance and the development of cardiovascular disease. Cardiovasc Diabetol 2018;17:122. https://doi.org/10.1186/s12933-018-0762-4.

American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2014;37:S81-90. doi: 10.2337/dc14-S081.

Govindarajan Venguidesvarane A, Jasmine A, Varadarajan S, et al. Prevalence of vascular complications among type 2 diabetic patients in a rural health center in South India. J Prim Care Community Health 2020;11:1-11. doi: 10.1177/2150132720959962.

Liu Z, Liu X, Ma Z, Guan T. Phytosterols in rice bran and their health benefits. Front Nutr 2023;10:1287405. https://doi.org/10.3389/fnut.2023.1287405.

Nikooyeh B, Zargaraan A, Ebrahimof S, et. al. Daily consumption of γ-oryzanol-fortified canola oil, compared with unfortified canola and sunflower oils, resulted in a better improvement of certain cardiometabolic biomarkers of adult subjects with type 2 diabetes: a randomized controlled clinical trial. Eur J Med Res 2023;28: 416. doi: 10.1186/s40001-023-01409-8.

Mattei L, Francisqueti-Ferron FV, Garcia JL, et. al. Antioxidant and anti-inflammatory properties of gamma- oryzanol attenuates insulin resistance by increasing GLUT- 4 expression in skeletal muscle of obese animals, Mol Cell Endocrinol 2021;537:111423. https://doi.org/10.1016/j.mce.2021.111423.

Pereira C, Lourenço VM, Menezes R, Brites C. Rice compounds with impact on diabetes control. Foods 2021;10:1992. doi: 10.3390/foods10091992.

Malik VS, Sudha V, Wedick NM, et al. Substituting brown rice for white rice on diabetes risk factors in India: a randomised controlled trial. Br J Nutr 2019;121:1389-97. doi: 10.1017/S000711451900076X.

Wang O, Liu J, Cheng Q, et al. Effects of ferulic acid and γ-oryzanol on high-fat and high-fructose diet-induced metabolic syndrome in rats. PLoS ONE 2015;10:e0118135. https://doi.org/10.1371/journal.pone.0118135.

Kozuka C, Sunagawa C, Ueda R, et. al. γ-oryzanol protects pancreatic β-cells against endoplasmic reticulum stress in male mice. Endocrinology 2015;156:1242–50. doi: 10.1210/en.2014-1748.

Müller TD, Finan B, Bloom SR, et al. Glucagon-like peptide 1 (GLP-1). Mol Metab 2019;30:72-130. doi: 10.1016/j.molmet.2019.09.010.

Kozuka C, Sunagawa C, Ueda R, et. al. A novel insulinotropic mechanism of whole grain-derived γ-oryzanol via the suppression of local dopamine D2 receptor signalling in mouse islet. Br J Pharmacol 2015;172:4519–34. doi: 10.1111/bph.13236.

Caturano A, D'Angelo M, Mormone A, et al. Oxidative stress in type 2 diabetes: impacts from pathogenesis to lifestyle modifications. Curr Issues Mol Biol 2023;45:6651-66. doi: 10.3390/cimb45080420.

González P, Lozano P, Ros G, Solano F. Hyperglycemia and oxidative stress: an integral, updated and critical overview of their metabolic interconnections. Int J Mol Sci 2023;24:9352. doi: 10.3390/ijms24119352.

Sansenya S, Payaka A, Mansalai P. Inhibitory efficacy of cycloartenyl ferulate against -glucosidase and -amylase and its increased concentration in gamma-irradiated rice (germinated rice). Prev Nutr Food Sci 2023;28: 170-7. doi: 10.3746/pnf.2023.28.2.170.

Chauhan K, Chauhan B. Rice bran oil and oryzanol attenuates dyslipidemia and oxidative stress in atherogenic diet fed rats. Int J Med Pharmaceut Sci 2015;5:53-68.

Kozuka C, Shimizu-Okabe C, Takayama C, et. al. Marked augmentation of PLGA nanoparticle-induced metabolically beneficial impact of γ-oryzanol on fuel dyshomeostasis in genetically obese-diabetic ob/ob mice. Drug Deliv 2017;24: 558–68. doi: 10.1080/10717544.2017.1279237.

Guo XX, Zeng Z, Qian YZ, et. al. Wheat flour, enriched with γ-oryzanol, phytosterol, and ferulic acid, alleviates lipid and glucose metabolism in high-fat-fructose-fed rats. Nutrients 2019;11: 1697. doi:10.3390/nu11071697.

Bhaskaragoud, G, Chatterjee, P, Kumar, GS. Effect of oryzanol concentrate on hypolipidemic properties and antioxidant enzymes of liver in high fat fed and low STZ induced-male Wistar rats. Biomedicine 2020; 40:25-31.

Lin HL, Lin SH, Shen KP, et al. Efficiency comparison of PGBR extract and γ-oryzanol in antioxidative stress and anti-inflammatory properties against metabolic syndrome. J Food Biochem 2020;44:e13129. doi: 10.1111/jfbc.13129.

Nakayama T, Nagai Y, Uehara Y, et. al. Eating glutinous brown rice twice a day for 8 weeks improves glycemic control in Japanese patients with diabetes mellitus. Nutr Diabetes 2017;7: e273. doi:10.1038/nutd.2017.26.

Masuzaki H, Kozuka C, Okamoto S, Yonamine M, Tanaka H, Shimabukuro M. Brown rice-specific γ-oryzanol as a promising prophylactic avenue to protect against diabetes mellitus and obesity in humans. J Diabetes Investig 2019;10: 18-25. doi: 10.1111/jdi.12892.

Bumrungpert A, Lilitchan S, Tuntipopipat S, Tirawanchai N, Komindr S. Ferulic acid supplementation improves lipid profiles, oxidative stress, and inflammatory status in hyperlipidemic subjects: a randomized, double-blind, placebo-controlled clinical trial. Nutrients 2018;10:713. doi: 10.3390/nu10060713.

Luo L, Liu M. Adipose tissue in control of metabolism. J Endocrinol 2016;231:R77–R99. doi: 10.1530/JOE-16-0211.

Parimisetty A, Dorsemans AC, Awada R, Ravanan P, Diotel N, Lefebvre d’Hellencourt, C. Secret talk between adipose tissue and central nervous system via secreted factors-an emerging frontier in the neurodegenerative research. J Neuroinflammation 2016;13:67. doi: 10.1186/s12974-016-0530-x.

Clemente-Suárez VJ, Redondo-Flórez L, Beltrán-Velasco AI, et al. The role of adipokines in health and disease. Biomedicines 2023;11:1290. doi: 10.3390/biomedicines11051290.

Kirichenko TV, Markina YV, Bogatyreva AI, Tolstik TV, Varaeva YR, Starodubova AV. The role of adipokines in inflammatory mechanisms of obesity. Int J Mol Sci 2022;23:14982. doi: 10.3390/ijms232314982.

Peng J, Chen Q, Wu C. The role of adiponectin in cardiovascular disease. Cardiovasc Pathol 2023; 64:107514. https://doi.org/10.1016/j.carpath.2022.107514.

Francisqueti FV, Minatel IO, Ferron AJT, et. al. Effect of gamma-oryzanol as therapeutic agent to prevent cardiorenal metabolic syndrome in animals submitted to high sugar-fat diet. Nutrients 2017;9:1299. doi: 10.3390/nu9121299.

Hirano T. Pathophysiology of diabetic dyslipidemia. J Atheroscler Thromb 2018;25:771–82. doi: 10.5551/jat.RV17023.

Daya R, Bayat Z, Raal FJ. Prevalence and pattern of dyslipidemia in type 2 diabetes mellitus patients at a tertiary care hospital. J Endocrinol Metabol Diabetes South Africa 2017;22:31–5. doi: 10.1080/16089677.2017.1360064.

Ambachew H, Shimelis T, Lemma K. Dyslipidemia among diabetic patients in Southern Ethiopia. J Diabetes Endocrinol 2015;6:19–24. doi:10.5897/JDE2015.0086.

Pappan N, Awosika AO, Rehman A. Dyslipidemia. Treasure Island (FL): StatPearls Publishing; 2025.